What is CFH?
Founded in 2014, CFH, Ltd. operates as a vertically integrated hemp bioscience enterprise, recognized as a premier supplier of CBD across the United States. The company's core mission revolves around the production of superior full-spectrum CBD and proprietary hemp strains. These products are meticulously developed to preserve the natural balance of cannabinoids and terpenes inherent in hemp plants, thereby maximizing health benefits and efficacy. Beyond CBD, CFH's offerings, derived from hemp flower, feature a comprehensive profile of cannabinoids, terpenes, and flavonoids, catering to a growing demand for natural wellness solutions.
How much funding has CFH raised?
CFH has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for CFH?
With the recent influx of capital and its designation as a large-scale, late-stage funding event, CFH is strategically positioned for significant expansion. This substantial backing suggests a focus on scaling operations, potentially enhancing research and development into novel hemp-derived compounds, and broadening its market reach. The company's commitment to quality and its established supply chain indicate a trajectory towards solidifying its leadership in the competitive bioscience sector, likely exploring further strategic partnerships or market penetration initiatives.
See full CFH company page
